Skip to content

Skin Conditioning

TRANEXAMOYL DIPEPTIDE-33

85

Safety score · 0–100

Good

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

A dipeptide conjugate of tranexamic acid — designed to nudge melanin pathways for a more even tone. Topically benign at cosmetic levels; the prescription-drug status of tranexamic acid applies to systemic dosing only.

Function

HUMECTANTSKIN CONDITIONING - MISCELLANEOUS

Skin benefits

  • Targeted skin-tone evening
  • Tranexamic-acid-derived brightening
  • Combines with peptide signalling
  • Generally well tolerated

Known concerns

  • Tranexamic acid is a prescription drug at systemic doses (not relevant topically)
  • Limited independent cosmetic clinical data
  • Rare peptide allergy

References

EU

EU CosIng database

European Commission cosmetic ingredient registry: regulatory status, restrictions, authorised functions.

Related skin conditionings

Check your shelf

Find TRANEXAMOYL DIPEPTIDE-33 in your products.

Scan any cosmetic product with LuxSense to see if it contains TRANEXAMOYL DIPEPTIDE-33 and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve, so always read the physical product label and consult a healthcare professional for personal concerns.